New electrocardiographic score for the prediction of atrial fibrillation: The MVP ECG risk score (morphology‐voltage‐P‐wave duration)

dc.contributor.authorAlexander, Bryce
dc.contributor.authorMilden, Julia
dc.contributor.authorHazim, Bachar
dc.contributor.authorHaseeb, Sohaib
dc.contributor.authorBayés Genís, Antoni
dc.contributor.authorElosua, Roberto
dc.contributor.authorMartínez Sellés Oliveria Soares, Manuel
dc.contributor.authorYeung, Cynthia
dc.contributor.authorHopman, Wilma
dc.contributor.authorBaranchuk, Adrian
dc.contributor.authorEt al.
dc.date.accessioned2020-03-25T15:51:59Z
dc.date.available2020-03-25T15:51:59Z
dc.date.issued2019
dc.description.abstractBackground Atrial fibrillation (AF) is the most common arrhythmia and has significant morbidity. A score composed of easily measured electrocardiographic variables to identify patients at risk of AF would be of great value in order to stratify patients for increased monitoring and surveillance. The purpose of this study was to develop an electrocardiographic risk score for new‐onset AF. Methods A total of 676 patients without previous AF undergoing coronary angiography were retrospectively studied. Points were allocated based on P‐wave morphology in inferior leads, voltage in lead 1, and P‐wave duration (MVP). Patients were divided into three risk groups and followed until development of AF or last available clinical appointment. Results Mean age was 65 years, and 68% were male. The high‐ and intermediate‐risk groups were more likely to develop AF than the low‐risk group (odds ratio [OR] 2.4, 95% confidence interval [CI] 1.3–4.4; p = 0.006 and OR 2.1, 95% CI 1.4–3.27; p = 0.009, respectively). The high‐risk group had a significantly shorter mean time to development of AF (258 weeks; 95% CI 205–310 weeks) compared to the intermediate‐ (278 weeks; 95% CI 252–303 weeks) and low‐risk groups (322 weeks 95% CI 307–338 weeks), p = 0.005. Conclusions A simple risk score composed of easy‐to‐measure electrocardiographic variables can help to predict new‐onset AF. Further validation studies will be needed to assess the ability of this risk score to predict AF in other populations.spa
dc.description.filiationUEMspa
dc.description.impact1.131 JCR (2019) Q4, 125/138 Cardiac & Cardiovascular Systemsspa
dc.description.impact0.582 SJR (2019) Q2, 161/362 Cardiology and Cardiovascular Medicine, 1113/2754 Medicine (miscellaneous); Q3, 68/107 Physiology (medical)spa
dc.description.impactNo data IDR 2019spa
dc.description.sponsorshipSin financiaciónspa
dc.identifier.citationAlexander, B., Milden, J., Hazim, B., Haseeb, S., Bayés‐Genís, A., Elosúa, R., Martínez‐Sellés, M., Yeung, C., Hopman, W., Bayés de Luna, A., & Baranchuk, A. (2019). New electrocardiographic score for the prediction of atrial fibrillation: The MVP ECG risk score (morphology‐voltage‐P‐wave duration). Annals of Noninvasive Electrocardiology, 24(6), e12669. https://doi.org/10.1111/anec.12669spa
dc.identifier.doi10.1111/anec.12669
dc.identifier.issn1082-720X
dc.identifier.issn1542-474X
dc.identifier.urihttp://hdl.handle.net/11268/8843
dc.language.isoengspa
dc.peerreviewedSispa
dc.relation.publisherversionhttp://ezproxy.universidadeuropea.es/login?url=http://dx.doi.org/10.1111/anec.12669spa
dc.rights.accessRightsrestricted accessspa
dc.subject.uemCardiologíaspa
dc.subject.uemMedicina preventivaspa
dc.subject.uemElectrocardiografíaspa
dc.subject.unescoEnfermedad cardiovascularspa
dc.subject.unescoMedicina preventivaspa
dc.subject.unescoTecnología médicaspa
dc.titleNew electrocardiographic score for the prediction of atrial fibrillation: The MVP ECG risk score (morphology‐voltage‐P‐wave duration)spa
dc.typejournal articlespa
dspace.entity.typePublication
relation.isAuthorOfPublicationa14a4cbe-6878-47e7-8b7b-ffdd4a82573a
relation.isAuthorOfPublication.latestForDiscoverya14a4cbe-6878-47e7-8b7b-ffdd4a82573a

Files